Record Information |
---|
Version | 5.0 |
---|
Status | Detected but not Quantified |
---|
Creation Date | 2021-09-10 23:59:06 UTC |
---|
Update Date | 2021-09-26 22:56:22 UTC |
---|
HMDB ID | HMDB0246964 |
---|
Secondary Accession Numbers | None |
---|
Metabolite Identification |
---|
Common Name | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine |
---|
Description | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine belongs to the class of organic compounds known as aminoquinolines and derivatives. These are organic compounds containing an amino group attached to a quinoline ring system. Based on a literature review very few articles have been published on (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine. This compound has been identified in human blood as reported by (PMID: 31557052 ). (s)-n1-((1h-benzo[d]imidazol-2-yl)methyl)-n1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine is not a naturally occurring metabolite and is only found in those individuals exposed to this compound or its derivatives. Technically (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine is part of the human exposome. The exposome can be defined as the collection of all the exposures of an individual in a lifetime and how those exposures relate to health. An individual's exposure begins before birth and includes insults from environmental and occupational sources. |
---|
Structure | NCCCCN(CC1=NC2=CC=CC=C2N1)C1CCCC2=C1N=CC=C2 InChI=1S/C21H27N5/c22-12-3-4-14-26(15-20-24-17-9-1-2-10-18(17)25-20)19-11-5-7-16-8-6-13-23-21(16)19/h1-2,6,8-10,13,19H,3-5,7,11-12,14-15,22H2,(H,24,25) |
---|
Synonyms | Not Available |
---|
Chemical Formula | C21H27N5 |
---|
Average Molecular Weight | 349.482 |
---|
Monoisotopic Molecular Weight | 349.226645889 |
---|
IUPAC Name | N-(4-aminobutyl)-N-[(1H-1,3-benzodiazol-2-yl)methyl]-5,6,7,8-tetrahydroquinolin-8-amine |
---|
Traditional Name | N-(4-aminobutyl)-N-(1H-1,3-benzodiazol-2-ylmethyl)-5,6,7,8-tetrahydroquinolin-8-amine |
---|
CAS Registry Number | Not Available |
---|
SMILES | NCCCCN(CC1=NC2=CC=CC=C2N1)C1CCCC2=C1N=CC=C2 |
---|
InChI Identifier | InChI=1S/C21H27N5/c22-12-3-4-14-26(15-20-24-17-9-1-2-10-18(17)25-20)19-11-5-7-16-8-6-13-23-21(16)19/h1-2,6,8-10,13,19H,3-5,7,11-12,14-15,22H2,(H,24,25) |
---|
InChI Key | WVLHHLRVNDMIAR-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as aminoquinolines and derivatives. These are organic compounds containing an amino group attached to a quinoline ring system. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organoheterocyclic compounds |
---|
Class | Quinolines and derivatives |
---|
Sub Class | Aminoquinolines and derivatives |
---|
Direct Parent | Aminoquinolines and derivatives |
---|
Alternative Parents | |
---|
Substituents | - Aminoquinoline
- Tetrahydroquinoline
- Benzimidazole
- Aralkylamine
- Pyridine
- Benzenoid
- Imidazole
- Heteroaromatic compound
- Azole
- Tertiary aliphatic amine
- Tertiary amine
- Azacycle
- Amine
- Primary amine
- Organonitrogen compound
- Primary aliphatic amine
- Hydrocarbon derivative
- Organic nitrogen compound
- Aromatic heteropolycyclic compound
|
---|
Molecular Framework | Aromatic heteropolycyclic compounds |
---|
External Descriptors | Not Available |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Not Available |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | Not Available | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | Not Available | Not Available | LogP | Not Available | Not Available |
|
---|
Experimental Chromatographic Properties | Not Available |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Retention Times UnderivatizedChromatographic Method | Retention Time | Reference |
---|
Predicted by Siyang on May 30, 2022 | 9.3587 minutes | 33406817 | Predicted by Siyang using ReTip algorithm on June 8, 2022 | 4.38 minutes | 32390414 | Fem_Long = Waters ACQUITY UPLC HSS T3 C18 with Water:MeOH and 0.1% Formic Acid | 425.4 seconds | 40023050 | Fem_Lipids = Ascentis Express C18 with (60:40 water:ACN):(90:10 IPA:ACN) and 10mM NH4COOH + 0.1% Formic Acid | 175.5 seconds | 40023050 | Life_Old = Waters ACQUITY UPLC BEH C18 with Water:(20:80 acetone:ACN) and 0.1% Formic Acid | 123.7 seconds | 40023050 | Life_New = RP Waters ACQUITY UPLC HSS T3 C18 with Water:(30:70 MeOH:ACN) and 0.1% Formic Acid | 163.0 seconds | 40023050 | RIKEN = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 79.3 seconds | 40023050 | Eawag_XBridgeC18 = XBridge C18 3.5u 2.1x50 mm with Water:MeOH and 0.1% Formic Acid | 293.2 seconds | 40023050 | BfG_NTS_RP1 =Agilent Zorbax Eclipse Plus C18 (2.1 mm x 150 mm, 3.5 um) with Water:ACN and 0.1% Formic Acid | 295.1 seconds | 40023050 | HILIC_BDD_2 = Merck SeQuant ZIC-HILIC with ACN(0.1% formic acid):water(16 mM ammonium formate) | 1127.7 seconds | 40023050 | UniToyama_Atlantis = RP Waters Atlantis T3 (2.1 x 150 mm, 5 um) with ACN:Water and 0.1% Formic Acid | 620.1 seconds | 40023050 | BDD_C18 = Hypersil Gold 1.9µm C18 with Water:ACN and 0.1% Formic Acid | 53.8 seconds | 40023050 | UFZ_Phenomenex = Kinetex Core-Shell C18 2.6 um, 3.0 x 100 mm, Phenomenex with Water:MeOH and 0.1% Formic Acid | 512.4 seconds | 40023050 | SNU_RIKEN_POS = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 155.1 seconds | 40023050 | RPMMFDA = Waters ACQUITY UPLC BEH C18 with Water:ACN and 0.1% Formic Acid | 248.4 seconds | 40023050 | MTBLS87 = Merck SeQuant ZIC-pHILIC column with ACN:Water and :ammonium carbonate | 835.9 seconds | 40023050 | KI_GIAR_zic_HILIC_pH2_7 = Merck SeQuant ZIC-HILIC with ACN:Water and 0.1% FA | 612.9 seconds | 40023050 | Meister zic-pHILIC pH9.3 = Merck SeQuant ZIC-pHILIC column with ACN:Water 5mM NH4Ac pH9.3 and 5mM ammonium acetate in water | 384.9 seconds | 40023050 |
Predicted Kovats Retention IndicesUnderivatizedMetabolite | SMILES | Kovats RI Value | Column Type | Reference |
---|
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine | NCCCCN(CC1=NC2=CC=CC=C2N1)C1CCCC2=C1N=CC=C2 | 4204.2 | Standard polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine | NCCCCN(CC1=NC2=CC=CC=C2N1)C1CCCC2=C1N=CC=C2 | 3231.3 | Standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine | NCCCCN(CC1=NC2=CC=CC=C2N1)C1CCCC2=C1N=CC=C2 | 3226.2 | Semi standard non polar | 33892256 |
DerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
(S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,1TMS,isomer #1 | C[Si](C)(C)NCCCCN(CC1=NC2=CC=CC=C2[NH]1)C1CCCC2=CC=CN=C21 | 3406.2 | Semi standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,1TMS,isomer #1 | C[Si](C)(C)NCCCCN(CC1=NC2=CC=CC=C2[NH]1)C1CCCC2=CC=CN=C21 | 3301.1 | Standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,1TMS,isomer #1 | C[Si](C)(C)NCCCCN(CC1=NC2=CC=CC=C2[NH]1)C1CCCC2=CC=CN=C21 | 4426.7 | Standard polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,1TMS,isomer #2 | C[Si](C)(C)N1C(CN(CCCCN)C2CCCC3=CC=CN=C32)=NC2=CC=CC=C21 | 3373.6 | Semi standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,1TMS,isomer #2 | C[Si](C)(C)N1C(CN(CCCCN)C2CCCC3=CC=CN=C32)=NC2=CC=CC=C21 | 3242.8 | Standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,1TMS,isomer #2 | C[Si](C)(C)N1C(CN(CCCCN)C2CCCC3=CC=CN=C32)=NC2=CC=CC=C21 | 4533.0 | Standard polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,2TMS,isomer #1 | C[Si](C)(C)N(CCCCN(CC1=NC2=CC=CC=C2[NH]1)C1CCCC2=CC=CN=C21)[Si](C)(C)C | 3542.1 | Semi standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,2TMS,isomer #1 | C[Si](C)(C)N(CCCCN(CC1=NC2=CC=CC=C2[NH]1)C1CCCC2=CC=CN=C21)[Si](C)(C)C | 3540.4 | Standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,2TMS,isomer #1 | C[Si](C)(C)N(CCCCN(CC1=NC2=CC=CC=C2[NH]1)C1CCCC2=CC=CN=C21)[Si](C)(C)C | 4366.0 | Standard polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,2TMS,isomer #2 | C[Si](C)(C)NCCCCN(CC1=NC2=CC=CC=C2N1[Si](C)(C)C)C1CCCC2=CC=CN=C21 | 3420.9 | Semi standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,2TMS,isomer #2 | C[Si](C)(C)NCCCCN(CC1=NC2=CC=CC=C2N1[Si](C)(C)C)C1CCCC2=CC=CN=C21 | 3343.1 | Standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,2TMS,isomer #2 | C[Si](C)(C)NCCCCN(CC1=NC2=CC=CC=C2N1[Si](C)(C)C)C1CCCC2=CC=CN=C21 | 4182.4 | Standard polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,3TMS,isomer #1 | C[Si](C)(C)N(CCCCN(CC1=NC2=CC=CC=C2N1[Si](C)(C)C)C1CCCC2=CC=CN=C21)[Si](C)(C)C | 3584.8 | Semi standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,3TMS,isomer #1 | C[Si](C)(C)N(CCCCN(CC1=NC2=CC=CC=C2N1[Si](C)(C)C)C1CCCC2=CC=CN=C21)[Si](C)(C)C | 3551.6 | Standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,3TMS,isomer #1 | C[Si](C)(C)N(CCCCN(CC1=NC2=CC=CC=C2N1[Si](C)(C)C)C1CCCC2=CC=CN=C21)[Si](C)(C)C | 4080.1 | Standard polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCCCCN(CC1=NC2=CC=CC=C2[NH]1)C1CCCC2=CC=CN=C21 | 3628.1 | Semi standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCCCCN(CC1=NC2=CC=CC=C2[NH]1)C1CCCC2=CC=CN=C21 | 3580.9 | Standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,1TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)NCCCCN(CC1=NC2=CC=CC=C2[NH]1)C1CCCC2=CC=CN=C21 | 4496.9 | Standard polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(CN(CCCCN)C2CCCC3=CC=CN=C32)=NC2=CC=CC=C21 | 3580.2 | Semi standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(CN(CCCCN)C2CCCC3=CC=CN=C32)=NC2=CC=CC=C21 | 3499.6 | Standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,1TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)N1C(CN(CCCCN)C2CCCC3=CC=CN=C32)=NC2=CC=CC=C21 | 4568.2 | Standard polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCCCN(CC1=NC2=CC=CC=C2[NH]1)C1CCCC2=CC=CN=C21)[Si](C)(C)C(C)(C)C | 3991.4 | Semi standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCCCN(CC1=NC2=CC=CC=C2[NH]1)C1CCCC2=CC=CN=C21)[Si](C)(C)C(C)(C)C | 4008.6 | Standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,2TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCCCN(CC1=NC2=CC=CC=C2[NH]1)C1CCCC2=CC=CN=C21)[Si](C)(C)C(C)(C)C | 4401.0 | Standard polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NCCCCN(CC1=NC2=CC=CC=C2N1[Si](C)(C)C(C)(C)C)C1CCCC2=CC=CN=C21 | 3835.6 | Semi standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NCCCCN(CC1=NC2=CC=CC=C2N1[Si](C)(C)C(C)(C)C)C1CCCC2=CC=CN=C21 | 3852.0 | Standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,2TBDMS,isomer #2 | CC(C)(C)[Si](C)(C)NCCCCN(CC1=NC2=CC=CC=C2N1[Si](C)(C)C(C)(C)C)C1CCCC2=CC=CN=C21 | 4258.8 | Standard polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCCCN(CC1=NC2=CC=CC=C2N1[Si](C)(C)C(C)(C)C)C1CCCC2=CC=CN=C21)[Si](C)(C)C(C)(C)C | 4204.4 | Semi standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCCCN(CC1=NC2=CC=CC=C2N1[Si](C)(C)C(C)(C)C)C1CCCC2=CC=CN=C21)[Si](C)(C)C(C)(C)C | 4232.9 | Standard non polar | 33892256 | (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine,3TBDMS,isomer #1 | CC(C)(C)[Si](C)(C)N(CCCCN(CC1=NC2=CC=CC=C2N1[Si](C)(C)C(C)(C)C)C1CCCC2=CC=CN=C21)[Si](C)(C)C(C)(C)C | 4178.6 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine GC-MS (Non-derivatized) - 70eV, Positive | splash10-001i-7942000000-d1abef3c67dadc0819ed | 2021-09-24 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine 10V, Positive-QTOF | splash10-0udi-0309000000-faa70a5f1e140cd2af7a | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine 20V, Positive-QTOF | splash10-0f89-0219000000-02cd8da6ca84463454c3 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine 40V, Positive-QTOF | splash10-001i-2920000000-ed5dedcba6060c7dbc50 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine 10V, Negative-QTOF | splash10-0002-0009000000-6dccfe6f1f1aaeb6d09e | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine 20V, Negative-QTOF | splash10-0002-0109000000-4d5975e205d6306a2469 | 2021-10-12 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - (S)-N1-((1H-Benzo[d]imidazol-2-yl)methyl)-N1-(5,6,7,8-tetrahydroquinolin-8-yl)butane-1,4-diamine 40V, Negative-QTOF | splash10-0002-0910000000-28cd84159afbb660ea8f | 2021-10-12 | Wishart Lab | View Spectrum |
|
---|